Is the pharmaceutical industry good at innovation?
The prevailing view would perhaps be that the industry is not good at innovation, because it is conservative and risk averse. BPOG Director Simon Chalk shares his own views.
List view / Grid view
The prevailing view would perhaps be that the industry is not good at innovation, because it is conservative and risk averse. BPOG Director Simon Chalk shares his own views.
European Pharmaceutical Review has brought you the most up-to-date and relevant pharmaceutical science for the past 21 years. This anniversary supplement brings you a selection of topical views from across the industry, reviewing progress over that time, as well as looking to the future.